Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Christina Chatziaggelidou"'
Autor:
Charikleia Kelaidi, Marie-Christine Kyrtsonis, Sossana Delimpasi, Evgenia Verrou, Nikos Giannakoulas, Pavlina Konstantinidou, Eirini Katodritou, Maria Kotsopoulou, Kostas Zervas, Argiris Symeonidis, Christina Chatziaggelidou, Evangelos Terpos, Aikaterini Stefanoudaki, Nikos Spyridis, Meletios A. Dimopoulos, Vassiliki Gastari, Dimitrios Christoulas
Publikováno v:
American Journal of Hematology. 89:145-150
Plasma cell leukemia (PCL) is a rare and aggressive plasma cell disorder, with poor outcome. Bortezomib-based regimens (BBR) are highly effective in myeloma, but there is limited information about their efficacy and safety in PCL. Thus, we retrospect
Autor:
Eirini, Katodritou, Evangelos, Terpos, Charikleia, Kelaidi, Maria, Kotsopoulou, Sossana, Delimpasi, Marie-Christine, Kyrtsonis, Argiris, Symeonidis, Nikos, Giannakoulas, Aikaterini, Stefanoudaki, Dimitrios, Christoulas, Christina, Chatziaggelidou, Vassiliki, Gastari, Nikos, Spyridis, Evgenia, Verrou, Pavlina, Konstantinidou, Kostas, Zervas, Meletios A, Dimopoulos
Publikováno v:
American journal of hematology. 89(2)
Plasma cell leukemia (PCL) is a rare and aggressive plasma cell disorder, with poor outcome. Bortezomib-based regimens (BBR) are highly effective in myeloma, but there is limited information about their efficacy and safety in PCL. Thus, we retrospect
Autor:
Katodritou, Eirini, Terpos, Evangelos, Kelaidi, Charikleia, Kotsopoulou, Maria, Delimpasi, Sossana, Kyrtsonis, Marie-Christine, Symeonidis, Argiris, Giannakoulas, Nikos, Stefanoudaki, Aikaterini, Christoulas, Dimitrios, Chatziaggelidou, Christina, Gastari, Vassiliki, Spyridis, Nikos, Verrou, Evgenia, Konstantinidou, Pavlina, Zervas, Kostas, Dimopoulos, Meletios A.
Publikováno v:
American Journal of Hematology; Feb2014, Vol. 89 Issue 2, p145-150, 6p